Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global STD Rapid Antibody Test Market Outlook, In‑Depth Analysis & Forecast to 2031
Global STD Rapid Antibody Test Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 163 Pages
Report ld: 5344944
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
STD Rapid Antibody Test Market Size(US$)
CAGR 2025-2031
5.1%
Market Size,2031
USD 100
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 74.4 million
Market Forecast in 2031(Value)
US$ 100 million
CAGR
5.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global STD Rapid Antibody Test market is projected to grow from US$ 71.1 million in 2024 to US$ 100 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Sexually transmitted diseases (STDs) are those spread from a person to person through sexual contact. After the incubation period has passed, most STDs can be diagnosed via antibody-specific blood tests. Some STDs are also accompanied by lesions and can be diagnosed via swab, culture, or urine tests as well.
With the increasing openness of society, sexual health has gained significant attention. The STD Rapid Antibody Test has become an essential product in the market due to its rapid and convenient nature. This testing method can quickly detect antibodies related to various sexually transmitted diseases in a short period, aiding individuals in understanding their sexual health status and taking necessary measures for early treatment and prevention. Market trends indicate that modern individuals are placing a higher emphasis on health, particularly sexual health. As a result, there is a growing demand for STD Rapid Antibody Tests in medical facilities, sexual health institutions, and even through online retail channels. However, consumers are also becoming more concerned about the accuracy and reliability of such products. Manufacturers must rigorously ensure product quality to guarantee result accuracy and win the trust of consumers.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global STD Rapid Antibody Test market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Blue Cross Bio-Medical (Beijing)
- Guangzhou Wondfo Biotech
- OraSure
- Roche Diagnostics
- Abbott
- Bio-Rad Laboratories
- BioMerieux
- Creative Diagnostics
- Beijing Wantai Biological Pharmacy
- Chembio Diagnostic Systems
- InTec
- Meril Life
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Chlamydia Testing
- Gonorrhoea Testing
- Hepatitis C Testing
- HIV Testing
- Syphilis Testing
- Others
Segment by Application
- Hospital
- Homecare
- Diagnostic Centres
CHAPTER OUTLINE
Chapter 1: Defines the STD Rapid Antibody Test study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to STD Rapid Antibody Test: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global STD Rapid Antibody Test Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Chlamydia Testing
1.2.3 Gonorrhoea Testing
1.2.4 Hepatitis C Testing
1.2.5 HIV Testing
1.2.6 Syphilis Testing
1.2.7 Others
1.3 Market Segmentation by Application
1.3.1 Global STD Rapid Antibody Test Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Diagnostic Centres
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global STD Rapid Antibody Test Revenue Estimates and Forecasts 2020-2031
2.2 Global STD Rapid Antibody Test Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global STD Rapid Antibody Test Sales Estimates and Forecasts 2020-2031
2.4 Global STD Rapid Antibody Test Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global STD Rapid Antibody Test Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global STD Rapid Antibody Test Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Chlamydia Testing Market Size by Manufacturers
3.5.2 Gonorrhoea Testing Market Size by Manufacturers
3.5.3 Hepatitis C Testing Market Size by Manufacturers
3.5.4 HIV Testing Market Size by Manufacturers
3.5.5 Syphilis Testing Market Size by Manufacturers
3.5.6 Others Market Size by Manufacturers
3.6 Global STD Rapid Antibody Test Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global STD Rapid Antibody Test Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global STD Rapid Antibody Test Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global STD Rapid Antibody Test Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global STD Rapid Antibody Test Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America STD Rapid Antibody Test Sales and Revenue by Type (2020-2031)
6.4 North America STD Rapid Antibody Test Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America STD Rapid Antibody Test Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe STD Rapid Antibody Test Sales and Revenue by Type (2020-2031)
7.4 Europe STD Rapid Antibody Test Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe STD Rapid Antibody Test Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific STD Rapid Antibody Test Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific STD Rapid Antibody Test Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific STD Rapid Antibody Test Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America STD Rapid Antibody Test Sales and Revenue by Type (2020-2031)
9.4 Central and South America STD Rapid Antibody Test Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America STD Rapid Antibody Test Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa STD Rapid Antibody Test Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa STD Rapid Antibody Test Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa STD Rapid Antibody Test Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Blue Cross Bio-Medical (Beijing)
11.1.1 Blue Cross Bio-Medical (Beijing) Corporation Information
11.1.2 Blue Cross Bio-Medical (Beijing) Business Overview
11.1.3 Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test Product Models, Descriptions and Specifications
11.1.4 Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test Sales by Product in 2024
11.1.6 Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test Sales by Application in 2024
11.1.7 Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test Sales by Geographic Area in 2024
11.1.8 Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test SWOT Analysis
11.1.9 Blue Cross Bio-Medical (Beijing) Recent Developments
11.2 Guangzhou Wondfo Biotech
11.2.1 Guangzhou Wondfo Biotech Corporation Information
11.2.2 Guangzhou Wondfo Biotech Business Overview
11.2.3 Guangzhou Wondfo Biotech STD Rapid Antibody Test Product Models, Descriptions and Specifications
11.2.4 Guangzhou Wondfo Biotech STD Rapid Antibody Test Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Guangzhou Wondfo Biotech STD Rapid Antibody Test Sales by Product in 2024
11.2.6 Guangzhou Wondfo Biotech STD Rapid Antibody Test Sales by Application in 2024
11.2.7 Guangzhou Wondfo Biotech STD Rapid Antibody Test Sales by Geographic Area in 2024
11.2.8 Guangzhou Wondfo Biotech STD Rapid Antibody Test SWOT Analysis
11.2.9 Guangzhou Wondfo Biotech Recent Developments
11.3 OraSure
11.3.1 OraSure Corporation Information
11.3.2 OraSure Business Overview
11.3.3 OraSure STD Rapid Antibody Test Product Models, Descriptions and Specifications
11.3.4 OraSure STD Rapid Antibody Test Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 OraSure STD Rapid Antibody Test Sales by Product in 2024
11.3.6 OraSure STD Rapid Antibody Test Sales by Application in 2024
11.3.7 OraSure STD Rapid Antibody Test Sales by Geographic Area in 2024
11.3.8 OraSure STD Rapid Antibody Test SWOT Analysis
11.3.9 OraSure Recent Developments
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Corporation Information
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics STD Rapid Antibody Test Product Models, Descriptions and Specifications
11.4.4 Roche Diagnostics STD Rapid Antibody Test Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Roche Diagnostics STD Rapid Antibody Test Sales by Product in 2024
11.4.6 Roche Diagnostics STD Rapid Antibody Test Sales by Application in 2024
11.4.7 Roche Diagnostics STD Rapid Antibody Test Sales by Geographic Area in 2024
11.4.8 Roche Diagnostics STD Rapid Antibody Test SWOT Analysis
11.4.9 Roche Diagnostics Recent Developments
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Business Overview
11.5.3 Abbott STD Rapid Antibody Test Product Models, Descriptions and Specifications
11.5.4 Abbott STD Rapid Antibody Test Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Abbott STD Rapid Antibody Test Sales by Product in 2024
11.5.6 Abbott STD Rapid Antibody Test Sales by Application in 2024
11.5.7 Abbott STD Rapid Antibody Test Sales by Geographic Area in 2024
11.5.8 Abbott STD Rapid Antibody Test SWOT Analysis
11.5.9 Abbott Recent Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Corporation Information
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories STD Rapid Antibody Test Product Models, Descriptions and Specifications
11.6.4 Bio-Rad Laboratories STD Rapid Antibody Test Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Bio-Rad Laboratories Recent Developments
11.7 BioMerieux
11.7.1 BioMerieux Corporation Information
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux STD Rapid Antibody Test Product Models, Descriptions and Specifications
11.7.4 BioMerieux STD Rapid Antibody Test Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 BioMerieux Recent Developments
11.8 Creative Diagnostics
11.8.1 Creative Diagnostics Corporation Information
11.8.2 Creative Diagnostics Business Overview
11.8.3 Creative Diagnostics STD Rapid Antibody Test Product Models, Descriptions and Specifications
11.8.4 Creative Diagnostics STD Rapid Antibody Test Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Creative Diagnostics Recent Developments
11.9 Beijing Wantai Biological Pharmacy
11.9.1 Beijing Wantai Biological Pharmacy Corporation Information
11.9.2 Beijing Wantai Biological Pharmacy Business Overview
11.9.3 Beijing Wantai Biological Pharmacy STD Rapid Antibody Test Product Models, Descriptions and Specifications
11.9.4 Beijing Wantai Biological Pharmacy STD Rapid Antibody Test Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Beijing Wantai Biological Pharmacy Recent Developments
11.10 Chembio Diagnostic Systems
11.10.1 Chembio Diagnostic Systems Corporation Information
11.10.2 Chembio Diagnostic Systems Business Overview
11.10.3 Chembio Diagnostic Systems STD Rapid Antibody Test Product Models, Descriptions and Specifications
11.10.4 Chembio Diagnostic Systems STD Rapid Antibody Test Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Chembio Diagnostic Systems Recent Developments
11.11 InTec
11.11.1 InTec Corporation Information
11.11.2 InTec Business Overview
11.11.3 InTec STD Rapid Antibody Test Product Models, Descriptions and Specifications
11.11.4 InTec STD Rapid Antibody Test Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 InTec Recent Developments
11.12 Meril Life
11.12.1 Meril Life Corporation Information
11.12.2 Meril Life Business Overview
11.12.3 Meril Life STD Rapid Antibody Test Product Models, Descriptions and Specifications
11.12.4 Meril Life STD Rapid Antibody Test Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Meril Life Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 STD Rapid Antibody Test Industry Chain
12.2 STD Rapid Antibody Test Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 STD Rapid Antibody Test Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 STD Rapid Antibody Test Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 STD Rapid Antibody Test Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global STD Rapid Antibody Test Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global STD Rapid Antibody Test Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global STD Rapid Antibody Test Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global STD Rapid Antibody Test Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global STD Rapid Antibody Test Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global STD Rapid Antibody Test Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global STD Rapid Antibody Test Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global STD Rapid Antibody Test Sales by Region (2020-2025) & (K Units)
Table 8. Global STD Rapid Antibody Test Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global STD Rapid Antibody Test Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global STD Rapid Antibody Test Sales Share by Manufacturers (2020-2025)
Table 12. Global STD Rapid Antibody Test Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global STD Rapid Antibody Test Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global STD Rapid Antibody Test by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in STD Rapid Antibody Test as of 2024)
Table 16. Global STD Rapid Antibody Test Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global STD Rapid Antibody Test Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers STD Rapid Antibody Test Manufacturing Base and Headquarters
Table 19. Global STD Rapid Antibody Test Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global STD Rapid Antibody Test Sales by Type (2020-2025) & (K Units)
Table 23. Global STD Rapid Antibody Test Sales by Type (2026-2031) & (K Units)
Table 24. Global STD Rapid Antibody Test Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global STD Rapid Antibody Test Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global STD Rapid Antibody Test ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global STD Rapid Antibody Test Sales by Application (2020-2025) & (K Units)
Table 29. Global STD Rapid Antibody Test Sales by Application (2026-2031) & (K Units)
Table 30. STD Rapid Antibody Test High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global STD Rapid Antibody Test Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global STD Rapid Antibody Test Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global STD Rapid Antibody Test ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America STD Rapid Antibody Test Growth Accelerators and Market Barriers
Table 37. North America STD Rapid Antibody Test Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America STD Rapid Antibody Test Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe STD Rapid Antibody Test Growth Accelerators and Market Barriers
Table 40. Europe STD Rapid Antibody Test Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe STD Rapid Antibody Test Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific STD Rapid Antibody Test Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific STD Rapid Antibody Test Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific STD Rapid Antibody Test Growth Accelerators and Market Barriers
Table 45. Southeast Asia STD Rapid Antibody Test Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America STD Rapid Antibody Test Investment Opportunities and Key Challenges
Table 47. Central and South America STD Rapid Antibody Test Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa STD Rapid Antibody Test Investment Opportunities and Key Challenges
Table 49. Middle East and Africa STD Rapid Antibody Test Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Blue Cross Bio-Medical (Beijing) Corporation Information
Table 51. Blue Cross Bio-Medical (Beijing) Description and Major Businesses
Table 52. Blue Cross Bio-Medical (Beijing) Product Models, Descriptions and Specifications
Table 53. Blue Cross Bio-Medical (Beijing) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Blue Cross Bio-Medical (Beijing) Sales Value Proportion by Product in 2024
Table 55. Blue Cross Bio-Medical (Beijing) Sales Value Proportion by Application in 2024
Table 56. Blue Cross Bio-Medical (Beijing) Sales Value Proportion by Geographic Area in 2024
Table 57. Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test SWOT Analysis
Table 58. Blue Cross Bio-Medical (Beijing) Recent Developments
Table 59. Guangzhou Wondfo Biotech Corporation Information
Table 60. Guangzhou Wondfo Biotech Description and Major Businesses
Table 61. Guangzhou Wondfo Biotech Product Models, Descriptions and Specifications
Table 62. Guangzhou Wondfo Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Guangzhou Wondfo Biotech Sales Value Proportion by Product in 2024
Table 64. Guangzhou Wondfo Biotech Sales Value Proportion by Application in 2024
Table 65. Guangzhou Wondfo Biotech Sales Value Proportion by Geographic Area in 2024
Table 66. Guangzhou Wondfo Biotech STD Rapid Antibody Test SWOT Analysis
Table 67. Guangzhou Wondfo Biotech Recent Developments
Table 68. OraSure Corporation Information
Table 69. OraSure Description and Major Businesses
Table 70. OraSure Product Models, Descriptions and Specifications
Table 71. OraSure Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. OraSure Sales Value Proportion by Product in 2024
Table 73. OraSure Sales Value Proportion by Application in 2024
Table 74. OraSure Sales Value Proportion by Geographic Area in 2024
Table 75. OraSure STD Rapid Antibody Test SWOT Analysis
Table 76. OraSure Recent Developments
Table 77. Roche Diagnostics Corporation Information
Table 78. Roche Diagnostics Description and Major Businesses
Table 79. Roche Diagnostics Product Models, Descriptions and Specifications
Table 80. Roche Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Roche Diagnostics Sales Value Proportion by Product in 2024
Table 82. Roche Diagnostics Sales Value Proportion by Application in 2024
Table 83. Roche Diagnostics Sales Value Proportion by Geographic Area in 2024
Table 84. Roche Diagnostics STD Rapid Antibody Test SWOT Analysis
Table 85. Roche Diagnostics Recent Developments
Table 86. Abbott Corporation Information
Table 87. Abbott Description and Major Businesses
Table 88. Abbott Product Models, Descriptions and Specifications
Table 89. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Abbott Sales Value Proportion by Product in 2024
Table 91. Abbott Sales Value Proportion by Application in 2024
Table 92. Abbott Sales Value Proportion by Geographic Area in 2024
Table 93. Abbott STD Rapid Antibody Test SWOT Analysis
Table 94. Abbott Recent Developments
Table 95. Bio-Rad Laboratories Corporation Information
Table 96. Bio-Rad Laboratories Description and Major Businesses
Table 97. Bio-Rad Laboratories Product Models, Descriptions and Specifications
Table 98. Bio-Rad Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Bio-Rad Laboratories Recent Developments
Table 100. BioMerieux Corporation Information
Table 101. BioMerieux Description and Major Businesses
Table 102. BioMerieux Product Models, Descriptions and Specifications
Table 103. BioMerieux Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. BioMerieux Recent Developments
Table 105. Creative Diagnostics Corporation Information
Table 106. Creative Diagnostics Description and Major Businesses
Table 107. Creative Diagnostics Product Models, Descriptions and Specifications
Table 108. Creative Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Creative Diagnostics Recent Developments
Table 110. Beijing Wantai Biological Pharmacy Corporation Information
Table 111. Beijing Wantai Biological Pharmacy Description and Major Businesses
Table 112. Beijing Wantai Biological Pharmacy Product Models, Descriptions and Specifications
Table 113. Beijing Wantai Biological Pharmacy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Beijing Wantai Biological Pharmacy Recent Developments
Table 115. Chembio Diagnostic Systems Corporation Information
Table 116. Chembio Diagnostic Systems Description and Major Businesses
Table 117. Chembio Diagnostic Systems Product Models, Descriptions and Specifications
Table 118. Chembio Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Chembio Diagnostic Systems Recent Developments
Table 120. InTec Corporation Information
Table 121. InTec Description and Major Businesses
Table 122. InTec Product Models, Descriptions and Specifications
Table 123. InTec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. InTec Recent Developments
Table 125. Meril Life Corporation Information
Table 126. Meril Life Description and Major Businesses
Table 127. Meril Life Product Models, Descriptions and Specifications
Table 128. Meril Life Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Meril Life Recent Developments
Table 130. Key Raw Materials Distribution
Table 131. Raw Materials Key Suppliers
Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 133. Milestones in Production Technology Evolution
Table 134. Distributors List
Table 135. Market Trends and Market Evolution
Table 136. Market Drivers and Opportunities
Table 137. Market Challenges, Risks, and Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. STD Rapid Antibody Test Product Picture
Figure 2. Global STD Rapid Antibody Test Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Chlamydia Testing Product Picture
Figure 4. Gonorrhoea Testing Product Picture
Figure 5. Hepatitis C Testing Product Picture
Figure 6. HIV Testing Product Picture
Figure 7. Syphilis Testing Product Picture
Figure 8. Others Product Picture
Figure 9. Global STD Rapid Antibody Test Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 10. Hospital
Figure 11. Homecare
Figure 12. Diagnostic Centres
Figure 13. STD Rapid Antibody Test Report Years Considered
Figure 14. Global STD Rapid Antibody Test Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 16. Global STD Rapid Antibody Test Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global STD Rapid Antibody Test Revenue Market Share by Region (2020-2031)
Figure 18. Global STD Rapid Antibody Test Sales (2020-2031) & (K Units)
Figure 19. Global STD Rapid Antibody Test Sales (CAGR) by Region (2020-2031) (K Units)
Figure 20. Global STD Rapid Antibody Test Sales Market Share by Region (2020-2031)
Figure 21. Top 5 and Top 10 Manufacturers STD Rapid Antibody Test Sales Volume Market Share in 2024
Figure 22. Global STD Rapid Antibody Test Revenue Market Share Ranking (2024)
Figure 23. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 24. Chlamydia Testing Revenue Market Share by Manufacturer in 2024
Figure 25. Gonorrhoea Testing Revenue Market Share by Manufacturer in 2024
Figure 26. Hepatitis C Testing Revenue Market Share by Manufacturer in 2024
Figure 27. HIV Testing Revenue Market Share by Manufacturer in 2024
Figure 28. Syphilis Testing Revenue Market Share by Manufacturer in 2024
Figure 29. Others Revenue Market Share by Manufacturer in 2024
Figure 30. Global STD Rapid Antibody Test Sales Market Share by Type (2020-2031)
Figure 31. Global STD Rapid Antibody Test Revenue Market Share by Type (2020-2031)
Figure 32. Global STD Rapid Antibody Test Sales Market Share by Application (2020-2031)
Figure 33. Global STD Rapid Antibody Test Revenue Market Share by Application (2020-2031)
Figure 34. North America STD Rapid Antibody Test Sales YoY (2020-2031) & (K Units)
Figure 35. North America STD Rapid Antibody Test Revenue YoY (2020-2031) & (US$ Million)
Figure 36. North America Top 5 Manufacturers STD Rapid Antibody Test Sales Revenue (US$ Million) in 2024
Figure 37. North America STD Rapid Antibody Test Sales Volume (K Units) by Type (2020- 2031)
Figure 38. North America STD Rapid Antibody Test Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 39. North America STD Rapid Antibody Test Sales Volume (K Units) by Application (2020-2031)
Figure 40. North America STD Rapid Antibody Test Sales Revenue (US$ Million) by Application (2020-2031)
Figure 41. US STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 42. Canada STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 43. Mexico STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 44. Europe STD Rapid Antibody Test Sales YoY (2020-2031) & (K Units)
Figure 45. Europe STD Rapid Antibody Test Revenue YoY (2020-2031) & (US$ Million)
Figure 46. Europe Top 5 Manufacturers STD Rapid Antibody Test Sales Revenue (US$ Million) in 2024
Figure 47. Europe STD Rapid Antibody Test Sales Volume (K Units) by Type (2020-2031)
Figure 48. Europe STD Rapid Antibody Test Sales Revenue (US$ Million) by Type (2020-2031)
Figure 49. Europe STD Rapid Antibody Test Sales Volume (K Units) by Application (2020-2031)
Figure 50. Europe STD Rapid Antibody Test Sales Revenue (US$ Million) by Application (2020-2031)
Figure 51. Germany STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 52. France STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 53. U.K. STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 54. Italy STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 55. Russia STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 56. Asia-Pacific STD Rapid Antibody Test Sales YoY (2020-2031) & (K Units)
Figure 57. Asia-Pacific STD Rapid Antibody Test Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Asia-Pacific Top 8 Manufacturers STD Rapid Antibody Test Sales Revenue (US$ Million) in 2024
Figure 59. Asia-Pacific STD Rapid Antibody Test Sales Volume (K Units) by Type (2020- 2031)
Figure 60. Asia-Pacific STD Rapid Antibody Test Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 61. Asia-Pacific STD Rapid Antibody Test Sales Volume (K Units) by Application (2020-2031)
Figure 62. Asia-Pacific STD Rapid Antibody Test Sales Revenue (US$ Million) by Application (2020-2031)
Figure 63. Indonesia STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 64. Japan STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 65. South Korea STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 66. China Taiwan STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 67. India STD Rapid Antibody Test Revenue (2020-2031) & (US$ Million)
Figure 68. Central and South America STD Rapid Antibody Test Sales YoY (2020-2031) & (K Units)
Figure 69. Central and South America STD Rapid Antibody Test Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Central and South America Top 5 Manufacturers STD Rapid Antibody Test Sales Revenue (US$ Million) in 2024
Figure 71. Central and South America STD Rapid Antibody Test Sales Volume (K Units) by Type (2021-2031)
Figure 72. Central and South America STD Rapid Antibody Test Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Central and South America STD Rapid Antibody Test Sales Volume (K Units) by Application (2020-2031)
Figure 74. Central and South America STD Rapid Antibody Test Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. Brazil STD Rapid Antibody Test Revenue (2020-2025) & (US$ Million)
Figure 76. Argentina STD Rapid Antibody Test Revenue (2020-2025) & (US$ Million)
Figure 77. Middle East, and Africa STD Rapid Antibody Test Sales YoY (2020-2031) & (K Units)
Figure 78. Middle East and Africa STD Rapid Antibody Test Revenue YoY (2020-2031) & (US$ Million)
Figure 79. Middle East and Africa Top 5 Manufacturers STD Rapid Antibody Test Sales Revenue (US$ Million) in 2024
Figure 80. Middle East and Africa STD Rapid Antibody Test Sales Volume (K Units) by Type (2021-2031)
Figure 81. South America STD Rapid Antibody Test Sales Revenue (US$ Million) by Type (2020-2031)
Figure 82. Middle East and Africa STD Rapid Antibody Test Sales Volume (K Units) by Application (2020-2031)
Figure 83. Middle East and Africa STD Rapid Antibody Test Sales Revenue (US$ Million) by Application (2020-2031)
Figure 84. GCC Countries STD Rapid Antibody Test Revenue (2020-2025) & (US$ Million)
Figure 85. Turkey STD Rapid Antibody Test Revenue (2020-2025) & (US$ Million)
Figure 86. Egypt STD Rapid Antibody Test Revenue (2020-2025) & (US$ Million)
Figure 87. South Africa STD Rapid Antibody Test Revenue (2020-2025) & (US$ Million)
Figure 88. STD Rapid Antibody Test Industry Chain Mapping
Figure 89. Regional STD Rapid Antibody Test Manufacturing Base Distribution (%)
Figure 90. Global STD Rapid Antibody Test Production Market Share by Region (2020-2031)
Figure 91. STD Rapid Antibody Test Production Process
Figure 92. Regional STD Rapid Antibody Test Production Cost Structure
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global STD Rapid Antibody Test market?
The top companies in the global STD Rapid Antibody Test market are Blue Cross Bio-Medical (Beijing)、Guangzhou Wondfo Biotech、OraSure.
What was the global market size of STD Rapid Antibody Test in 2025?
What is the annual compound growth rate of the global STD Rapid Antibody Test market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of STD Rapid Antibody Test in 2031?
Related Reports
STD Rapid Antibody Test- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for STD Rapid Antibody Test was estimated to be worth US$ 74.39 million in 2025 and is projected to reach US$ 105 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 140
USD 3950.00
(Single User License)
Global STD Rapid Antibody Test Market Research Report 2026
The global STD Rapid Antibody Test market was valued at US$ 74.39 million in 2025 and is anticipated to reach US$ 105 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 126
USD 2900.00
(Single User License)
Global STD Rapid Antibody Test Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global STD Rapid Antibody Test market size was US$ 71.1 million in 2024 and is forecast to a readjusted size of US$ 100 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 94
USD 4250.00
(Single User License)
STD Rapid Antibody Test- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for STD Rapid Antibody Test was estimated to be worth US$ 71.1 million in 2024 and is forecast to a readjusted size of US$ 100 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 128
USD 3950.00
(Single User License)
Global STD Rapid Antibody Test Market Research Report 2025
The global market for STD Rapid Antibody Test was valued at US$ 71.1 million in the year 2024 and is projected to reach a revised size of US$ 100 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-01-13
Pages: 90
USD 2900.00
(Single User License)
Global STD Rapid Antibody Test Market Research Report 2024
Sexually transmitted diseases (STDs) are those spread from a person to person through sexual contact. After the incubation period has passed, most STDs can be diagnosed via antibody-specific blood tests. Some STDs are also accompanied by lesions and can be diagnosed via swab, culture, or urine tests as well.
Published Date: 2024-01-17
Pages: 93
USD 2900.00
(Single User License)
STD Rapid Antibody Test- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for STD Rapid Antibody Test was estimated to be worth US$ 74.39 million in 2025 and is projected to reach US$ 105 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-06-16
Pages: 140
USD 3950.00 (Single User License)Global STD Rapid Antibody Test Market Research Report 2026
The global STD Rapid Antibody Test market was valued at US$ 74.39 million in 2025 and is anticipated to reach US$ 105 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-04-17
Pages: 126
USD 2900.00 (Single User License)Global STD Rapid Antibody Test Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global STD Rapid Antibody Test market size was US$ 71.1 million in 2024 and is forecast to a readjusted size of US$ 100 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 94
USD 4250.00 (Single User License)STD Rapid Antibody Test- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for STD Rapid Antibody Test was estimated to be worth US$ 71.1 million in 2024 and is forecast to a readjusted size of US$ 100 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 128
USD 3950.00 (Single User License)Global STD Rapid Antibody Test Market Research Report 2025
The global market for STD Rapid Antibody Test was valued at US$ 71.1 million in the year 2024 and is projected to reach a revised size of US$ 100 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-01-13
Pages: 90
USD 2900.00 (Single User License)Global STD Rapid Antibody Test Market Research Report 2024
Sexually transmitted diseases (STDs) are those spread from a person to person through sexual contact. After the incubation period has passed, most STDs can be diagnosed via antibody-specific blood tests. Some STDs are also accompanied by lesions and can be diagnosed via swab, culture, or urine tests as well.
Published: 2024-01-17
Pages: 93
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now